Percy Carter

Discovery of deucravacitinib: A first-in-class, allosteric TYK2 inhibitor for the treatment of autoimmune diseases
Optimization of indole-based antagonists of toll-like receptors 7 and 8 (TLR7/8) through C-2 variations
Discovery of afimetoran, a small molecule dual antagonist of the toll-like receptors 7 and 8 (TLR7/8) advanced to clinical evaluation in patients with lupus
Macrocyclic peptides bind to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)

Item	Price	Remove